We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Occlutech has recruited the first patient in the FROST-HF study, which will investigate the company’s atrial flow regulator (AFR) device in the treatment of patients with heart failure.
PADM Medical Group of Companies has secured a 510(k) clearance for the PRECISION ECO Compostable / Plant Based Procedural Mask with Earloops from the US Food and Drug
Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and Leica Biosystems, a cancer diagnostics company and global leader in workflow solutions, today announced
Tyber Medical has secured the US Food and Drug Administration (FDA)’s 510(k) clearance for expanding its anatomical plate portfolio along with an additional clearance for MR Conditional labelling.
Alverno Laboratories and Ibex Medical Analytics have signed a new multi-year, multi-tissue agreement for expanding the deployment of the latter’s Galen suite of artificial intelligence (AI) solutions to
Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, today announced the availability of Mindpeak’s AI algorithms for IHC biomarker quantification in the Paige
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in
Augmedics, a US-based provider of augmented reality (AR) surgical navigation solutions, has launched new features and indications for its xvision Spine System. The AR-powered xvision Spine System has
Respiree has secured the 510(k) clearance from the US Food and Drug Administration (FDA) for its RS001 cardio-respiratory wearable. According to the digital therapeutics start-up, RS001 is a
Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced that the first two patients